Victory Capital Management’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-757
Closed -$8.15K 2521
2025
Q1
$8.15K Sell
757
-135
-15% -$1.65K ﹤0.01% 2461
2024
Q4
$11.4K Buy
892
+172
+24% +$3.41K ﹤0.01% 2467
2024
Q3
$19.9K Sell
720
-45
-6% -$1.32K ﹤0.01% 2445
2024
Q2
$22.2K Sell
765
-2
-0.3% -$95 ﹤0.01% 2424
2024
Q1
$34.2K Sell
767
-64
-8% -$2.74K ﹤0.01% 2407
2023
Q4
$32.2K Buy
831
+169
+26% +$6.09K ﹤0.01% 2476
2023
Q3
$19.5K Buy
662
+7
+1% +$332 ﹤0.01% 2448
2023
Q2
$41.7K Sell
655
-15
-2% -$830 ﹤0.01% 2403
2023
Q1
$31.6K Buy
+670
New +$35.8K ﹤0.01% 2478
2022
Q3
Sell
-1,158
Closed -$151K 2739
2022
Q2
$151K Sell
1,158
-8,473
-88% -$866K ﹤0.01% 2403
2022
Q1
$975K Sell
9,631
-688
-7% -$83.4K ﹤0.01% 1826
2021
Q4
$1.6M Sell
10,319
-175
-2% -$39K ﹤0.01% 1638
2021
Q3
$3.11M Buy
10,494
+852
+9% +$255K ﹤0.01% 1456
2021
Q2
$3.13M Buy
+9,642
New +$3.16M ﹤0.01% 1498

Other funds holding LYEL